What we're reading, July 26, 2016: revenues from Gilead's hepatitis C drugs continue to fall; Arizona's plan to unfreeze enrollment in CHIP has been approved; and Colombia declares an end to the Zika virus epidemic.
Revenues from Gilead’s hepatitis C virus (HCV) drugs continue to fall due to competition and pricing pressures. The Wall Street Journal reported that sales of HCV drugs fell 19% overall during the second quarter of 2016. Sales of Harvoni took a big hit (-29%), while Sovaldi sales saw a gain (5.2%). Gilead executives said the decrease in sales is a result of increased competition in the space and a mandatory price cut in Japan.
Arizona’s plan to unfreeze enrollment in the Children’s Health Insurance Program (CHIP) has been approved, making it the last state to provide coverage. Between 30,000 and 40,000 children will become newly eligible for healthcare coverage starting September 1, according to The Washington Post. The state had frozen enrollment for its KidsCare program in 2009 to save money after the recession and the program had been formally shut down in 2014.
Colombia has declared an end to the Zika virus epidemic in the country. While new cases will continue to appear, the country’s vice minister of health said that the outbreak has been controlled, according to STAT. The peak of the epidemic in Colombia was early February, when more than 6000 cases were reported in a week. The latest weekly survey reported fewer than 1000 cases. However, some experts believe declines in case in some countries could just be a seasonal drop rather than a true end to the outbreak.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More